UFP Industries remains a 'buy' despite recent revenue, profit, and cash flow declines driven by weak housing and end-market conditions. UFPI's strong balance sheet, with $534.2 million in net cash, provides stability and flexibility during ongoing market softness. Forward valuation is less attractive than last year, but UFPI trades at a reasonable EV/EBITDA multiple versus peers, supporting continued upside.
UFP Technologies, Inc. (UFPT) Q1 2026 Earnings Call Transcript
UFP Technologies (UFPT) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.47 per share a year ago.
| Health Care Equipment & Supplies Industry | Healthcare Sector | R. Jeffrey Bailly CEO | XFRA Exchange | 902673102 CUSIP |
| US Country | 4,846 Employees | - Last Dividend | - Last Split | 16 Dec 1993 IPO Date |
UFP Technologies, Inc. is a company specializing in the design and custom manufacturing of components, subassemblies, products, and packaging using specialized foams, films, and plastics with a primary focus on the medical market. Since its inception in 1963, the company has expanded its offerings to meet the needs of several other sectors, including automotive, aerospace and defense, consumer electronics, and industrial markets. Based in Newburyport, Massachusetts, UFP Technologies has cultivated a robust presence in the United States, leveraging a direct sales force and independent manufacturer representatives to market and sell its innovative solutions.
UFP Technologies, Inc. offers a diverse portfolio of products and services across various industries: